Clinical Trial: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase II Study Of Amifostine In Children With Myelodysplastic Syndrome

Brief Summary:

RATIONALE: Drugs used in chemotherapy, such as amifostine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.

PURPOSE: This phase II trial is studying how well amifostine works in treating young patients with newly diagnosed de novo myelodysplastic syndromes.